Judd Moul, MD

CONTACT

Lead Sponsor

Duke University

Collaborators

Age

40 - No limit years

Sex

MALE

Healthy Volunteers

No

•Eligibility criteria
•Patients ≥ 40 years of age
•All patients with suspicion of PCa
•Men ≥ 40 years of age attending Duke Health/Urology with suspicion of prostate cancer (Primary disease) will be approached to consent for the study. Upon consent, samples will be obtained alone, during repeat PSA/other biomarkers testing, or during imaging at Duke Lab.

•Men who have previously undergone treatment for prostate cancer.
•Men with prior diagnosis of prostate cancer.
•Men with severe, irreversible coagulopathy.
•Men on anticoagulant therapies or those who have taken antiplatelet agents such as aspirin, NSAIDs (ibuprofen, entrophen, naproxen, diclofenac etc), clopidrogel, prasugrel, ticagrelor, or dipyridamole in the 7 days preceding blood collection.